Advisor Group Holdings, Inc. Bridge Bio Pharma, Inc. Transaction History

Advisor Group Holdings, Inc.

$67.1 Billion
Q3 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 260,058 shares of BBIO stock, worth $17.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

260,058

Previous 4,167 6140.89%

Holding current value

$17.3 Million

Previous $179,000 7445.81%

% of portfolio

0.02%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$42.78 - $54.29 $10.9 Million - $13.9 Million	255,891 Added 6140.89%	260,058 $13.5 Million
Q2 2025 Sep 04, 2025	BUY	$30.14 - $45.12 $61,636 - $92,270	2,045 Added 96.37%	4,167 $179,000
Q2 2025 Aug 13, 2025	BUY	$30.14 - $45.12 $24,503 - $36,682	813 Added 62.11%	2,122 $91,000
Q1 2025 May 12, 2025	SELL	$28.12 - $37.59 $492,268 - $658,050	-17,506 Reduced 93.04%	1,309 $45,000
Q4 2024 Jun 06, 2025	BUY	$22.35 - $29.5 $42,934 - $56,669	1,921 Added 146.75%	3,230 $88,000

Q4 2024 Feb 07, 2025	BUY	$22.35 - $29.5 $1,586 - $2,094	71 Added 0.38%	18,815 $516,000
Q3 2024 Nov 13, 2024	SELL	$23.91 - $31.3 $24,962 - $32,677	-1,044 Reduced 5.28%	18,744 $477,000
Q2 2024 Aug 13, 2024	BUY	$23.0 - $31.04 $44,114 - $59,534	1,918 Added 10.73%	19,788 $501,000
Q1 2024 May 10, 2024	BUY	$27.35 - $40.45 $55,356 - $81,870	2,024 Added 12.77%	17,870 $552,000
Q4 2023 Feb 12, 2024	BUY	$24.02 - $43.89 $324,005 - $592,032	13,489 Added 572.3%	15,846 $639,000
Q3 2023 Nov 13, 2023	BUY	$16.89 - $35.01 $2,263 - $4,691	134 Added 6.03%	2,357 $62,000
Q2 2023 Aug 10, 2023	BUY	$13.29 - $18.01 $2,365 - $3,205	178 Added 8.7%	2,223 $38,000
Q1 2023 May 12, 2023	BUY	$7.17 - $18.55 $1,684 - $4,359	235 Added 12.98%	2,045 $33,000
Q4 2022 Feb 10, 2023	SELL	$6.74 - $11.52 $303 - $518	-45 Reduced 2.43%	1,810 $13,000
Q3 2022 Nov 14, 2022	SELL	$7.94 - $12.36 $682 - $1,062	-86 Reduced 4.43%	1,855 $18,000
Q2 2022 Aug 10, 2022	BUY	$5.21 - $12.14 $687 - $1,602	132 Added 7.3%	1,941 $18,000
Q1 2022 May 04, 2022	SELL	$7.34 - $17.16 $1,453 - $3,397	-198 Reduced 9.87%	1,809 $18,000
Q2 2021 Aug 02, 2021	BUY	$46.47 - $63.93 $15,846 - $21,800	341 Added 20.47%	2,007 $122,000
Q1 2021 May 13, 2021	SELL	$55.47 - $72.35 $6,767 - $8,826	-122 Reduced 6.82%	1,666 $102,000
Q4 2020 Feb 10, 2021	BUY	$38.38 - $71.11 $18,537 - $34,346	483 Added 37.01%	1,788 $127,000
Q2 2020 Aug 14, 2020	BUY	$22.22 - $35.69 $10,554 - $16,952	475 Added 57.23%	1,305 $43,000
Q1 2020 May 18, 2020	BUY	$16.11 - $36.23 $13,371 - $30,070	830 New	830 $24,000

Others Institutions Holding BBIO

# of Institutions

445

Shares Held

184M

Call Options Held

11.3M

Put Options Held

1.84M

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $9.84B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Bridge Bio Pharma, Inc. Transaction History